BREAKING NEWS: FDA Approves First Treatment for Friedreich’s Ataxia. LEARN MORE!
Menu
The Clinical Research Consortium for the Study of Cerebellar Ataxia (CRC-SCA) continues to collect longitudinal data and biospecimens for research participants who have a confirmed diagnosis of SCA 1, 2, 3, 6, 7, 8 or 10. The following data is available to the Academic Research Community by following the process below.
1. Review the policy and follow the guidelines.
2. Fill out Appendix 1 from the guidelines and attach your scientific proposal.
3. Send Appendix 1 and your proposal to Dr. Sheng-Han Kuo.
Please follow the instructions available here and concurrently contact Dr. Sheng-Han Kuo.
Our generous donors help us fund promising Ataxia research and offer support services to people with Ataxia. Your gift today will help us continue to deliver on our mission to improve the lives of persons affected by Ataxia.
Join for FREE today! Become a part of the community that is working together to find a cure. As a member you will receive access to the latest Ataxia news with our e-newsletter and Generations publication.
501(c)(3)
EIN 41-0832903
Mailing Address:
PO Box 27986
Golden Valley, MN 55427
Physical Address:
600 Highway 169 South
Suite 1725
Minneapolis, MN 55426
763-553-0020
763-553-0167 (Fax)
Sign up today to receive: